New drugs haven’t brought about any significant improvement in the treatment of progressive multiple sclerosis. For a variety of reasons. Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase. Many patients, however, devel more
To use all functions of this page, please activate cookies in your browser.